SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Fader who wrote (2704)10/21/2000 10:08:49 PM
From: Mike M   of 5582
 
Eric there are probably good and bad times to short any company. I am incredulous that someone would be so stupid to short this company at the beginning of the cold season.

I think you hit it right on the head. We will be hearing an awful lot about Zicam and the Hirt study for the next several weeks. That is great publicity and FREE.

Just about the time the commotion dies down the preventive study is likely to hit the news. If that is positive, as I believe it will be, this stock may go berserk. The difference, duration versus prevention, is significant. For starters, no one has ever had a claim on prevention. I would be very surprised if big Pharma is not sniffing around for a deal.

Perhaps in severe market weakness this stock had another point or so on the downside short term. Doesn't even look like these bozos have the general market direction in their favor in the short run. Why someone would risk the upside potential of this company for that little bit boggles the mind. As the shorts begin to crumble they will find themselves at the mercy of shareholders.

Again I am just incredulous.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext